Daniel Krizek is a Portfolio Manager at Surveyor Capital, where he focuses on investments across the biotechnology sector. Prior to joining Surveyor, Mr. Krizek served as Director at Bain Capital / Brookside Fund, where he managed investments in biotechnology, med-tech, and diagnostics. Beside public equities, Mr. Krizek also focuses on private investments in highly innovative biotech companies, ranging from venture capital stage to mezzanine / pre-IPO. Before Bain Capital, Mr. Krizek was a consultant at McKinsey, where he advised companies in pharmaceutical, biotech, and med-tech sectors.
Mr. Krizek received a B.A. from Stanford, and holds CFA and CAIA designations.